GlassScriptPhysician profile
Kris John Storkersen
NPI 1154438935
$3,407.54
in general payments reported to CMS, 2019-2025
18 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $619 · 2021: $769 · 2022: $270 · 2023: $351 · 2024: $432 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,252.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,123.82 | 2019-2022 | |
| Dompe US, INC. | $560.57 | 2021-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $448.45 | 2019-2021 | |
| Alcon Vision LLC | $307.27 | 2019-2025 | Rocklatan, Argos |
| Horizon Therapeutics Plc | $244.72 | 2022-2023 | Tepezza |
| Amgen INC. | $172.54 | 2024-2025 | Tepezza |
| Sight Sciences, INC. | $99.16 | 2019-2023 | Omni Surgical System |
| Mallinckrodt Hospital Products INC. | $98.06 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $62.73 | 2025 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Shire North American Group INC | $59.81 | 2019 | |
| Glaukos Corporation | $49.31 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Ivantis, INC | $48.60 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $37.30 | 2022-2023 | Lotemax Sm, Vyzulta |
| Novartis Pharmaceuticals Corporation | $20.98 | 2020 | |
| Oyster Point Pharma, INC. | $20.97 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $19.78 | 2024 | Vevye |
| Abbvie INC. | $17.73 | 2022 | |
| Thea Pharma INC. | $15.74 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kris Storkersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.